GLycaemic Outcomes With Whey Protein in ageING
ConditionType 2 Diabetes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age75-90
SponsorUniversity of Birmingham
About this trial
The goal of this placebo-controlled, partial crossover design study is to identify the impact of consuming whey protein before meals on free-living glucose control in older adults living with type 2 diabetes.
The primary specific objective is to determine the effect of a thrice daily whey protein pre-meal supplementation at two doses, on glucose excursions over a 7-day free-living period in adults aged 75-90 years of age, living with type 2 diabetes, compared with a non-protein placebo.
Participants will consume the whey protein and placebo for 7 days each, before each meal. All participants will consume the placebo and one of two doses of whey protein, in a randomised order.
Eligibility criteria
Qualifiers
Male or female
75-90 years old
Type 2 Diabetes (confirmed with glycated haemoglobin (HbA1c) >6.5% in clinic or in SportExR)
Stable body mass (body mass index (BMI) ≤40kg/m2)
Disqualifiers
<75 years old and over 90 years of age
Currently on fast-acting insulin therapy (i.e., Humalog)
Confirmed uncontrolled diabetes (HbA1C >10% or 85mmol/mol).
Currently on GLP-1 therapy
Trial design
Treatments tested in this trial
- Glycaemic control with whey protein
- Glycaemic control with different doses of whey protein
Treatment groups
32 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Birmingham
Lead sponsor
Newcastle University
Collaborator
Source ClinicalTrials.gov